HHCL is a main Division of Hetero Healthcare Ltd with a clear intent of becoming a strong Healthcare Solution provider. At HHCL, we achieve customer satisfaction by providing products and services.
GENX a Division of Hetero Healthcare is one of the major contributors to Hetero Healthcare Ltd. having a turnover of 1200 million. GENX is committed to providing products and services of quality.
KRIS Division that started in 2010, today KRIS commands the highest growth with a progressive trend. Today, with a domestic market share of 1.01 percent in its represented market and the business growing three-fold between 2010-2015.
Hetero Healthcare Ltd begun its marketing operations in India with the launch of Antiretrovirals (ARVs) and has gained prominence in the field of HIV/AIDS.
Hetero Oncology commercializes portfolio of Oncology and Hematology products to address the unmet medical needs of people with cancer and related diseases.
Hetero Hepatology is committed towards creating awareness about Hepatitis B and C, providing access to high quality medicines at affordable rates and enriching lives of patients.
Hetero Healthcare have come to the world to help millions with a new approach to Diabetes management digitally. We offer complete solutions to Diabetes management (Dia) with & (Spa like) Rejuvenation.
Hetero Health Care R & D Centre had developed across a vast area. A striking feature of Hetero Health care is the well-planned and comprehensive infrastructure provided at this division.
VOLGA a super speciality division with focus on Urology & Nephrology ailments has been launched in the year 2016. The initial focus in Nephrology segment is anaemia caused due to CKD.
In the Paediatric segment Frenza addressing Paediatric Respiratory & Gastroenterology issues. In Gynaecology addresses the woman healthcare from Conception to Lactation and Vaginal Wellness.
The purpose of launching Alpha Division (Generics) was to ensure our presence with the masses even at the micro interiors. We at Hetero, believes in giving quality of medicines at affordable prices.
Hetero Healthcare's Radiant division started in the year 2019, is committed towards creating innovative skin care products. Radiant is committed to providing products and services of quality.
The biologics vertical was conceptualized in the year 2009. With the identification of key Biosimilars and helmed by a multi-disciplinary team of over 200 specialists, R&D commenced soon at the Hetero Research Foundation(HRF).